Nyvepria Alternatives Compared
| Nyvepria (pegfilgrastim) | Cefepime | Amoxicillin / clavulanate |
|
|---|
| Nyvepria (pegfilgrastim) | Cefepime | Amoxicillin / clavulanate |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Febrile Neutropenia. Nyvepria may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Kidney Infections, Bacteremia, Intraabdominal Infection, Febrile Neutropenia, Nosocomial Pneumonia, Pneumonia, Skin and Structure Infection, Skin or Soft Tissue Infection, Urinary... View more |
Prescription only
Amoxicillin/clavulanate is a combination penicillin-type antibiotic that should be reserved for the treatment of infections caused by susceptible beta-lactamase-producing bacteria. Its use may be... View more |
Related suggestions Febrile Neutropenia
|
|||||||||||||||||||||||
| More about Nyvepria (pegfilgrastim) | More about Cefepime | More about Amoxicillin / clavulanate | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Cefepime has an average rating of 8.0 out of 10 from a total of 5 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 0% reported a negative effect. |
Amoxicillin / clavulanate has an average rating of 5.3 out of 10 from a total of 910 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 42% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Nyvepria side effects |
View all Cefepime side effects |
|
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Nyvepria prices |
View all Cefepime prices |
View all Amoxicillin / clavulanate prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other pegfilgrastim brands include: Fulphila, Fylnetra, Neulasta, Stimufend, Udenyca, Ziextenzo | Maxipime | Amoclan, Augmentin, Augmentin XR | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
80 hours |
N/A |
1.7 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 178 drugs are known to interact with Nyvepria:
|
A total of 52 drugs are known to interact with Cefepime:
|
A total of 91 drugs are known to interact with Amoxicillin / clavulanate:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
January 18, 1996 |
August 06, 1984 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.